Copper(II) protects yeast against the toxicity of cisplatin independently of the induction of metallothionein and the inhibition of platinum uptake

Biochemical and Biophysical Research Communications

Volumn 310, Issue 1, 2003, Pages 148-152

  Ohashi, Kazuaki ^a   Kajiya, Kazuki ^a   Inaba, Sachiko ^a   Hasegawa, Tatsuya ^b   Seko, Yoshiyuki ^b   Furuchi, Takemitsu ^a,c   Naganuma, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b YAMANASHI INSTITUTE OF ENVIRONMENTAL SCIENCES   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Cisplatin; Copper; Metallothionein; Resistance; Yeast

Indexed keywords

CISPLATIN; COPPER SULFATE; METALLOTHIONEIN;

AGAR MEDIUM; ARTICLE; CELL FUNCTION; CELL PROTECTION; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG INHIBITION; DRUG UPTAKE; GENE DISRUPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SACCHAROMYCES CEREVISIAE;

MAMMALIA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0141514433     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.008     Document Type: Article

References (38)

1. Chu G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J. Biol. Chem. 269:1994;787-790.
2. Yoshida M., Khokhar A.R., Siddik Z.H. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Cancer Res. 54:1994;3468-3473.
3. Zwelling L.A., Kohn K.W. Mechanism of action of cis-dichlorodiammineplatinum (II). Cancer Treat. Rep. 63:1979;1439-1444.
4. Fujii R., Mutoh M., Niwa K., Yamada K., Aikou T., Nakagawa M., Kuwano M., Akiyama S. Active efflux system for cisplatin in cisplatin-resistant human KB cells. Jpn. J. Cancer Res. 85:1994;426-433.
5. Shen D., Pastan I., Gottesman M.M. Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res. 58:1998;268-275.
6. Hromas R.A., North J.A., Burns C.P. Decreased cisplatin uptake by resistant L1210 leukemia cells. Cancer Lett. 36:1987;197-201.
7. Waud W.R. Differential uptake of cis-diamminedichloroplatinum(II) by sensitive and resistant murine L1210 leukemia cells. Cancer Res. 47:1987;6549-6555.
8. Anderson M.E., Naganuma A., Meister A. Protection against cisplatin toxicity by administration of glutathione ester. FASEB J. 4:1990;3251-3255.
9. Arrick B., Nathan C.F. Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res. 44:1984;4424-4432.
10. Ikeda K., Miura K., Himeno S., Imura N., Naganuma A. Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum. Mol. Cell. Biochem. 219:2001;51-56.
11. Ishikawa T., Wright C.D., Ishizuka H. GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. J. Biol. Chem. 269:1994;29085-29093.
12. Godwin A.K., Meister A., O'Dwyer P.J., Huang C.S., Hamilton T.C., Anderson M.E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA. 89:1992;3070-3074.
13. Kelley S.L., Basu A., Teicher B.A., Hacker M.P., Hamer D.H., Lazo J.S. Overexpression of metallothionein confers resistance to anticancer drugs. Science. 241:1988;1813-1815.
14. Naganuma A., Satoh M., Imura N. Effect of copper pretreatment on toxicity and antitumor activity of cis-diamminedichloroplatinum in mice. Res. Commun. Chem. Pathol. Pharmacol. 46:1984;265-270.
15. Naganuma A., Satoh M., Imura N. Protective effect of metallothionein inducing metals on lethal toxicity of cis-dimminedichloroplatinum in mice. Toxicol. Lett. 24:1985;203-207.
16. Naganuma A., Satoh M., Imura N. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res. 47:1987;983-987.
17. Johnson S.W., Swiggard P.A., Handel L.M., Brennan J.M., Godwin A.K., Ozols R.F., Hamilton T.C. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res. 54:1994;5911-5916.
18. Dabholkar M., Reed E. Cisplatin. Cancer Chemother. Biol. Response Modif. 16:1996;88-110.
19. Gosland M., Lum B., Schimmelpfennig J., Baker J., Doukas M. Insights into mechanisms of cisplatin resistance and potential for its clinical reversal. Pharmacotherapy. 16:1996;16-39.
20. Lai G.M., Ozols R.F., Smyth J.F., Young R.C., Hamilton T.C. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem. Pharmacol. 37:1988;4597-4600.
21. Masuda H., Ozols R.F., Lai G.M., Fojo A., Rothenberg M., Hamilton T.C. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res. 48:1988;5713-5716.
22. Masumoto N., Nakano S., Fujishima H., Kohno K., Niho Y. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells. Int. J. Cancer. 80:1999;731-737.
23. Furuchi T., Ishikawa H., Miura N., Ishizuka M., Kajiya K., Kuge S., Naganuma A. Two nuclear proteins, Cin5 and Ydr259c, that confer resistance to cisplatin in Saccharomyces cerevisiae. Mol. Pharmacol. 59:2001;470-474.
24. Naganuma A., Miura N., Kaneko S., Mishina T., Hosoya S., Miyairi S., Furuchi T., Kuge S. GFAT as a target molecule of methylmercury toxicity in Saccharomyces cerevisiae. FASEB J. 14:2000;968-972.
25. Hwang G.W., Furuchi T., Naganuma A. A ubiquitin-proteasome system is responsible for the protection of yeast and human cells against methylmercury. FASEB J. 16:2002;709-711.
26. Furuchi T., Hwang G.W., Naganuma A. Overexpression of the ubiquitin-conjugating enzyme Cdc34 confers resistance to methylmercury in Saccharomyces cerevisiae. Mol. Pharmacol. 61:2002;738-741.
27. Lin X., Okuda T., Holzer A., Howell S.B. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol. Pharmacol. 62:2002;1154-1159.
28. Ishida S., Lee J., Thiele D.J., Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. USA. 99:2002;14298-14302.
29. Dancis A., Haile D., Yuan D.S., Klausner R.D. The Saccharomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake. J. Biol. Chem. 269:1994;25660-25667.
30. Ooi C.E., Rabinovich E., Dancis A., Bonifacino J.S., Klausner R.D. Copper-dependent degradation of the Saccharomyces cerevisiae plasma membrane copper transporter Ctr1p in the apparent absence of endocytosis. EMBO J. 15:1996;3515-3523.
31. Webb M. The Chemistry. Biochem. Biol. Cadmium. 1979;195-266.
32. Bakka A., Endresen L., Johnsen A.B., Edminson P.D., Rugstad H.E. Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol. Appl. Pharmacol. 61:1981;215-226.
33. Endresen L., Bakka A., Rugstad H.E. Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res. 43:1983;2918-2926.
34. Okazaki Y., Miura N., Satoh M., Imura N., Naganuma A. Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice. Biochem. Biophys. Res. Commun. 245:1998;815-818.
35. Butt T.R., Sternberg E.J., Gorman J.A., Clark P., Hamer D., Rosenberg M., Crooke S.T. Copper metallothionein of yeast, structure of the gene, and regulation of expression. Proc. Natl. Acad. Sci. USA. 81:1984;3332-3336.
36. Carri M.T., Galiazzo F., Ciriolo M.R., Rotilio G. Evidence for co-regulation of Cu, Zn superoxide dismutase and metallothionein gene expression in yeast through transcriptional control by copper via the ACE 1 factor. FEBS Lett. 278:1991;263-266.
37. Karin M., Najarian R., Haslinger A., Valenzuela P., Welch J., Fogel S. Primary structure and transcription of an amplified genetic locus: the CUP1 locus of yeast. Proc. Natl. Acad. Sci. USA. 81:1984;337-341.
38. Thiele D.J. ACE1 regulates expression of the Saccharomyces cerevisiae metallothionein gene. Mol. Cell. Biol. 8:1988;2745-2752.